Compare ZTS & MSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTS | MSCI |
|---|---|---|
| Founded | 1952 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7B | 40.3B |
| IPO Year | 2012 | 2007 |
| Metric | ZTS | MSCI |
|---|---|---|
| Price | $117.44 | $595.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | $155.18 | ★ $682.44 |
| AVG Volume (30 Days) | ★ 2.7M | 500.5K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | ★ 1.80% | 1.39% |
| EPS Growth | 10.05 | ★ 11.67 |
| EPS | ★ 6.02 | 5.53 |
| Revenue | ★ $9,467,000,000.00 | $1,274,172,000.00 |
| Revenue This Year | $5.63 | $12.56 |
| Revenue Next Year | $4.77 | $8.39 |
| P/E Ratio | ★ $19.59 | $107.33 |
| Revenue Growth | ★ 2.28 | N/A |
| 52 Week Low | $113.30 | $501.08 |
| 52 Week High | $172.23 | $626.28 |
| Indicator | ZTS | MSCI |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 63.45 |
| Support Level | $115.35 | $531.55 |
| Resistance Level | $130.52 | $600.00 |
| Average True Range (ATR) | 3.00 | 15.02 |
| MACD | -0.11 | 4.39 |
| Stochastic Oscillator | 30.59 | 71.27 |
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. MSCI boasts over $18 trillion in benchmarked assets, including over $2.3 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. In its sustainability and climate segment, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.